Licensing agreements give Bio Matrix Research and Filgen access to OGT's Southern array patents, the fundamental patents covering the manufacture and marketing of oligonucleotide microarrays
The granted microarray license will enable Bio Matrix Research , a bio venture company launched by Tokyo University of Science, to develop and commercialise unique products and to manufacture and market microarrays in Japan.
Filgen , a biochip and nanofilm technologies company is licensed to conduct a microarray service, using licensed microarrays, in Japan.
Michael Bennett, vice president licensing Asia at OGT said: "These two licenses continue the rapid progress of OGT's Japanese licensing programme, where we have granted licenses to both large multinational companies and small start up organisations.
"These licenses serve to illustrate the broad range of microarray patent rights that OGT offers, and that OGT works to ensure that any organisation can obtain access to the Southern patents, regardless of its size."
